Package Leaflet: Information for the User
Alopurinol pensa 300 mg tablets EFG
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Alopurinol Pensa belongs to a group of medications called enzyme inhibitors, which act by controlling the speed at which a certain chemical process occurs in the body. In this case, it results in a decrease in the level of uric acid in plasma and in urine.
This medication is used to prevent the onset of gout and other situations caused by excessive uric acid in the body, such as, for example, kidney stones and certain types of renal or metabolic diseases.
Warnings and Precautions
Be especially careful with this medication:
You should discontinue your treatment and contact your doctor as soon as possible if, while taking alopurinol, you experience any of the following symptoms:
It is possible that an acute gout attack may occur at the beginning of treatment with alopurinol. Your doctor will recommend the use of certain medications to prevent this. If a gout attack occurs, it is not necessary to discontinue treatment with alopurinol as long as an appropriate anti-inflammatory medication is used concurrently.
Severe skin reactions (hypersensitivity syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported with the use of alopurinol. Often, the rash may include ulcers in the mouth, throat, nose, genitals, and conjunctivitis (inflammation and redness of the eyes). These life-threatening skin eruptions are often preceded by flu-like symptoms such as fever, headache, and body aches. The rash may progress to the formation of blisters and generalized skin peeling. These severe skin reactions may be more common in people of Chinese Han, Thai, or Korean origin. Additionally, having chronic renal insufficiency may increase the risk in these patients. If you develop a skin rash or these skin symptoms, stop taking alopurinol and consult your doctor immediately.
The period of highest risk of severe skin reactions is during the first weeks of treatment.
If you have developed Stevens-Johnson syndrome or toxic epidermal necrolysis with the use of alopurinol, you should not use alopurinol again at any time.
Other Medications and Alopurinol Pensa
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication, especially the following. Your doctor may need to reduce the dose of your medication or monitor you more closely because there is a higher risk of side effects when Alopurinol Pensa is taken at the same time as: 6-mercaptopurine (used to treat blood cancer), azathioprine (used to inhibit the immune system), arabinoside of adenine (vidarabine, for the treatment of viral infections), salicylates (aspirin, for pain relief), uricosuric agents (probenecid, for gout treatment), chlorpropamide (for diabetes), theophylline (for asthma), phenytoin (for epilepsy), ampicillin (antibiotic), amoxicillin (antibiotic), cyclophosphamide (for rheumatoid arthritis and certain types of cancer), doxorubicin (for the treatment of certain types of lymphomas), bleomycin (for the treatment of certain types of cancer), procarbazine (for the treatment of certain types of cancer), mechlorethamine (for the treatment of certain types of cancer), cyclosporine (to prevent transplant rejection), anticoagulant coumarins to prevent blood clotting) and didanosine (for HIV treatment) and captopril.
Administration of 6-mercaptopurine or azathioprine with alopurinol should be avoided. When 6-mercaptopurine or azathioprine is administered with Alopurinol Pensa, the dose of 6-mercaptopurine or azathioprine should be reduced because its activity will be prolonged. This may increase the risk of severe blood disorders. In this case, your doctor will closely monitor your blood count during treatment.
Seek medical attention immediately if you notice any unexplained bruising, bleeding, fever, or sore throat.
If you are taking aluminum hydroxide concurrently, alopurinol may be reduced in effect, so leave a gap of at least 3 hours between taking both medications.
Administration of alopurinol in combination with cytostatics (e.g. cyclophosphamide, doxorubicin, bleomycin, procarbazine, alkylating agents) results in more frequent blood disorders than when these active ingredients are administered alone.
Therefore, regular hematological controls should be performed.
Pregnancy, Breastfeeding, and Fertility
If you are pregnant, think you may be pregnant, or are breastfeeding your child, consult your doctor or pharmacist before using this medication.
Alopurinol is not recommended for use during pregnancy.
Alopurinol passes into breast milk. Alopurinol is not recommended for use during breastfeeding.
Driving and Operating Machines
Due to its side effects (drowsiness, dizziness, and coordination impairment), this medication may impair your ability to drive vehicles.
Do not drive, operate tools, or machines until you are reasonably sure that the medication does not limit your abilities.
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medication.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Generally, your doctor will start treatment with alopurinol at a low dose (e.g., 100 mg/day) to reduce the risk of possible adverse effects. Your dose will be increased if necessary.
The groove is only for breaking the tablet if it is difficult to swallow it whole.
The recommended dose is:
Adults:
The recommended starting dose is 100 mg to 300 mg of alopurinol per day. The dose can be increased up to 900 mg per day, depending on the case. In this case, and if stomach discomfort appears, it is recommended to divide the dose into several daily doses and take them with food.
Children and adolescents under 15 years
The usual dose of this medication in children is 100 mg to 400 mg per day.
Older patients
Your doctor will recommend the lowest possible dose of alopurinol to reduce uric acid levels and control your symptoms.
Patients with liver or kidney dysfunction
If you have liver or kidney problems, your doctor will prescribe the lowest possible dose of alopurinol that can reduce uric acid levels and control your symptoms. In the case of renal insufficiency, your doctor may advise you to take less than 100 mg per day or to take single doses of 100 mg at intervals greater than one day.
If you are on dialysis 2 or 3 times a week, your doctor may prescribe a dose of 300-400 mg immediately after each dialysis session.
If you take more Alopurinol Pensa than you should
In this case, consult the Toxicological Information Service, Teléfono 91 562 04 20, or visit your doctor.
In case of accidental ingestion of a large amount of medication, go to your doctor immediately or to the nearest hospital emergency department. Bring this leaflet with you.
If you forgot to take Alopurinol Pensa
Do not take a double dose to compensate for the missed doses.
If you forget to take a dose, take the next dose as soon as you remember. Then, continue taking it as you normally do.
If you forget several doses, it is best to contact your doctor to decide what to do from then on.
If you interrupt treatment with Alopurinol Pensa:
Your doctor will indicate the duration of treatment with this medication. Do not stop treatment before, even if you feel better.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
The frequency of side effects is classified as:
Very common (in at least 1 in 10 patients).
Common (in at least 1 in 100 patients).
Uncommon (in at least 1 in 1,000 patients).
Rare (in at least 1 in 10,000 patients).
Very rare (less than 1 in 10,000 patients).
Frequency unknown (cannot be estimated from available data).
Infections and infestations:
Blood and lymphatic system disorders:
In some cases, allopurinol tablets may cause effects on the blood that manifest with the appearance of more frequent bruises, sore throat, or other signs of infection. These effects usually occur in people with kidney or liver problems. Inform your doctor as soon as possible if you have any of these symptoms.
Diagnostic procedures:
Immune system disorders:
Very rarely, seizures, wheezing (pits), palpitations, chest tightness, or loss of consciousness may occur.
Metabolism and nutrition disorders:
Mental and behavioral disorders:
Nervous system disorders:
Eye disorders:
Ear and labyrinth disorders:
Cardiac disorders:
Vascular disorders:
Gastrointestinal disorders:
Hepatobiliary disorders:
Skin and subcutaneous tissue disorders:
Musculoskeletal and connective tissue disorders:
Renal and urinary disorders:
Reproductive and breast disorders:
General disorders and administration site conditions:
If you experience any of the following symptoms, stop taking the medicine and inform your doctor immediately:
Rare (affects fewer than 1 in 1,000 people)
Cases of fever with or without evident signs or symptoms of generalized hypersensitivity to allopurinol have been reported (see Immune system disorders).
Do not be alarmed by this list of side effects, as it is possible that none of them will occur in your case.
Reporting of adverse reactions:
If you experience any type of adverse reaction, consult your doctor or pharmacist, even if it is a possible adverse reaction that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use:https://www.notificaram.es. By reporting adverse reactions, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
No special storage conditions are required. Store in the original packaging.
Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Alopurinol Pensa:
The active ingredient is alopurinol. Each tablet contains 300 mg of alopurinol.
The other components (excipients) are: lactose, sodium croscarmellose, povidone K-30, and magnesium stearate.
Appearance of the product and content of the packaging:
Alopurinol Pensa are white, round, uncoated tablets on one side and scored on the other, approximately 12 mm in diameter. Each package contains 30 or 500 (clinical package) tablets conditioned in PVC/aluminum blisters.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Responsible for manufacturing:
Towa Pharmaceutical Europe, S.L.
C/ de Sant Martí 75-97
08107 Martorelles (Barcelona)
Spain
Last review date of this leaflet:November 2024
The detailed information of this medication is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.